Records containing: Inclusion Body Myositis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Environmental Risk Factors for the Development of Myositis in Military Personnel
-
CLINICAL_TRIALS study record update · 2026-04-24Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies
-
CLINICAL_TRIALS study record update · 2026-04-17Surveying the Dietary Intake, Physical Activity Patterns, Muscle Strength and Morphology of Adults With Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2026-03-17Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults withNeuromuscular Disease
-
CLINICAL_TRIALS study record update · 2026-02-18Influence of NT5c1A Antibodies on Disease Progression, Clinical Phenotype and Blood and Muscle Biomarkers in Sporadic Inclusion Body Myositis - A Prospective Evaluation (INSPIRE-IBM Study)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-29A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of ABC008 in the Treatment of Subjects With Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2026-01-28MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) - A Qualitative Study of Patient-voiced Research Priorities Across Rare Myositis Diseases
-
CLINICAL_TRIALS study record update · 2026-01-14A Double-Blind Randomised Controlled Trial (dbRCT) Phase III Trial Investigating the Effect of Sirolimus on Disease Progression in Patients With Inclusion Body Myositis (IBM) as Measured by the IBM Functional Rating Scale (IBM-FRS)
-
CLINICAL_TRIALS study record update · 2026-01-07Emerging Indications for Hyperbaric Oxygen Treatment
-
CLINICAL_TRIALS study record update · 2025-12-17Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
-
CLINICAL_TRIALS study record update · 2025-09-10Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
-
CLINICAL_TRIALS study record update · 2025-07-18The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
-
CLINICAL_TRIALS study record update · 2025-07-04Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
-
CLINICAL_TRIALS study record update · 2025-02-20A Phase 1, Open-Label, Single and Multiple Ascending Dose Study of ABC008 in Adult Patients With Inclusion Body Myositis (IBM)
-
CLINICAL_TRIALS study record update · 2024-09-19The FBIndex to Determine the Risk of Falls and Its Translation to Assistive Gait Device Care for Patients With Neuromuscular Disorders
-
CLINICAL_TRIALS study record update · 2024-09-19Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2023-10-10Pompe & Pain - Observational Study to Assess Musculoskeletal Pain in Late-onset Pompe Disease (LOPD)
-
CLINICAL_TRIALS study record update · 2023-09-15An Open-label, Non-randomized Trial to Investigate the Efficacy and Safety of Early Versus Delayed Start of Arimoclomol in Patients With Sporadic Inclusion Body Myositis Who Have Completed the IBM4809 Trial
-
CLINICAL_TRIALS study record update · 2023-05-10Phase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM)
-
CLINICAL_TRIALS study record update · 2023-03-22Molecular Profile of the Evolution of Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2023-03-22Cell Therapy for Inclusion Body Myositis (IBM) by Muscle Injection of Autologous Uncultured Adipose-Derived Stromal Vascular Fraction (ADSVF): a Phase I Trial
-
CLINICAL_TRIALS study record update · 2021-01-12An Open-Label Pilot Study of Pioglitazone in Sporadic Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2020-08-11Application of Electrical Impedance Myography (EIM) to Establish Muscle Impedance Parameters as a Potential Biomarker of Inclusion Body Myositis (IBM)
-
CLINICAL_TRIALS study record update · 2017-01-19Safety and Tolerability Trial of Arimoclomol for Sporadic Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2014-05-29Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis